Jarushka Naidoo (@drjnaidoo) 's Twitter Profile
Jarushka Naidoo

@drjnaidoo

Professor of Medical Oncology @CancerCentreIre | Thoracic Oncologist | Immunotherapy & Immune toxicity | Adjunct faculty Johns Hopkins University

ID: 972549291867889666

linkhttps://scholar.google.com/citations?user=MSEo30cAAAAJ&hl=en calendar_today10-03-2018 19:06:35

4,4K Tweet

9,9K Followers

966 Following

Jarushka Naidoo (@drjnaidoo) 's Twitter Profile Photo
Jarushka Naidoo
@drjnaidoo

4 months ago

#ASCO24 Plenary🔥 Ph III ADRIATIC trial of consolidation Durva +/-Treme post cCRT for LS SCLC: - benefit in mOS 55.9 v 33.4m (HR 0.73, p=0.01) & mPFS 16.6 v 9.2m - pneu 10.7% & RT pneu 22.4%* First advance in 30+yrs in LS SCLC @asco ESMO - Eur. Oncology IASLC OncoAlert David R. Spigel, MD, FASCO #LCSM

#ASCO24 Plenary🔥 Ph III ADRIATIC trial of consolidation Durva +/-Treme post cCRT for LS SCLC: - benefit in mOS 55.9 v 33.4m (HR 0.73, p=0.01) &amp; mPFS 16.6 v 9.2m - pneu 10.7% &amp; RT pneu 22.4%* First advance in 30+yrs in LS SCLC @asco <a href="/myESMO/">ESMO - Eur. Oncology</a> <a href="/IASLC/">IASLC</a> <a href="/OncoAlert/">OncoAlert</a> <a href="/DavidRSpigel/">David R. Spigel, MD, FASCO</a> #LCSM